Skip to main content

Chairman of the Board - Stefano Vella

Dr. Stefano Vella

Stefano Vella (born in Rome, June 12, 1952) received his degree in Medicine from the University of Rome in 1977. He subsequently achieved specialty degrees in both Infectious Diseases (1982) and Internal Medicine (1987). After a postdoctoral experience at the University of Pennsylvania (1981-1982), he joined the medical staff at the Institute of Internal Medicine, University La Sapienza, Rome, where he developed an extensive experience in the clinical management of internal medicine and infectious diseases patients.

In 1991, Stefano Vella was appointed Research Director of HIV/AIDS at the Istituto Superiore di Sanità (ISS), the Italian National Institute of Health. Since 2003, he is the Head of the Department of Pharmacology and Therapeutic Research of the ISS, where he direct and supervise 270 staff members working on different areas of human therapeutics. The scientific and operational focus of Stefano Vella has been mainly based on his infectious diseases and internal medicine backgrounds. His work in resource limited setting also concerns tuberculosis, viral hepatitis, neglected tropical diseases, emerging chronic diseases and health systems strenghtening.

Specific work has been conducted by Stefano Vella and his research group on the clinical development of antiretroviral therapy; the study of HIV resistance to antiretroviral drugs; the mechanisms of immune reconstitution; the care and treatment of co-infections, including TB; the area of health needs assessment; the area of operational and implementation research in resource limited settings. At the beginning of the era of potent combinations of antiretroviral treatment, he chaired - or participated to seminal clinical studies on antiretroviral therapy. He was then elected President of the International AIDS Society [IAS] (2000-2002), actively working towards promoting access to treatment and care in the South of the World. He was instrumental to moving to Africa the International AIDS Conference (Durban, South Africa, 2000) which became the turning point in the fight against inequalities in access to care and treatment. Stefano Vella is involved in the setting of many operational and implementation programs in Uganda, South Africa, Mozambique, Tanzania, and Ethiopia. He served on the Technical Review Panel (TRP) of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), where he acquired an extensive experience in the evaluation of country programs to fight poverty-related diseases and subsequently served as the Italian board member (2006-2007).

From 2003 till 2016, Stefano Vella chaired the the Department of Pharmacology and Therapeutics at the Istituto Superiore di Sanità (the Italian National Institute of Health) where he directed the research activities of over 270 staff members, exploring innovation in therapeutics for different human disease areas, both communicable and non-communicable.

From 2004 until 2008, he served as a member of the Scientific Advice Working Group (SAWG) of the European Medicines Agency (EMA), where he acquired an extensive expertise in the regulatory aspects of the clinical development of medicines, in different human disease areas, from the preclinical phase to phase III clinical trials.

Stefano Vella is Vice President of the Scientific Council, ANRS/INSERM, Paris, France, special advisor to UNAIDS (Geneva) and to the Medicines Patent Pool (UNITAID, WHO). He Co-Chaired, the 2013 WHO Consolidated Guidelines on HIV Treatment and Care, and is a member of the Core Group, 2016 Guidelines.

Stefano Vella, has been invited plenary speaker in over 200 International Conferences, an article reviewer for numerous journals, including Science, Lancet, Journal of Infectious Diseases, AIDS, JAIDS, and published more than 3000 articles in international journals, including The New England Journal of Medicine, Lancet, JAMA, British Medical Journal, Annals of Internal Medicine (Citations: >  16.000; H-index: 52)

Curriculum Vitae

E-mailsegreteria.presidenza@aifa.gov.it

Data aggiornamento: May 2017
Skip to main content Skip to the top of the page